Health · 1 sources covering this

STAT+: Pharmalittle: We’re reading about a U.S. rule on Chinese deals, Belgium refusing Mounjaro coverage, and more

U.S. is poised to issue a proposed rule that would subject outbound licensing deals with Chinese biotech companies to additional scrutiny

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: Pharmalittle: We’re reading about a U.S. rule on Chinese deals, Belgium refusing Mounjaro coverage, and more
U.S. is poised to issue a proposed rule that would subject outbound licensing deals with Chinese biotech companies to additional scrutiny
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/6581cccdbe62dbbaae00245fdecc747ea3712949"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about a U.S. rule on Chinese deals, Belgium refusing Mounjaro coverage, and more"></iframe>

STAT+: Pharmalittle: We’re reading about a U.S. rule on Chinese deals, Belgium refusing Mounjaro coverage, and more

How 1 sources are covering this

STAT+: Pharmalittle: We’re reading about a U.S. rule on Chinese deals, Belgium refusing Mounjaro coverage, and more

More from Health

STAT+: What to expect from the Moderna-Merck cancer vaccine data reveal

STAT+: FDA has finalized its guidance on apps related to drugs

Health insurance premiums jump 9%, and more Americans don’t have access to coverage

Job-Based Health Plan Costs Rise, With Little Relief in Sight

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Pharmalittle: We&#8217;re reading about a U.S. rule on Chinese deals, Belgium refusing Mounjaro coverage, and more

More from Health

STAT+: What to expect from the Moderna-Merck cancer vaccine data reveal

STAT+: FDA has finalized its guidance on apps related to drugs

Health insurance premiums jump 9%, and more Americans don’t have access to coverage

Job-Based Health Plan Costs Rise, With Little Relief in Sight

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about a U.S. rule on Chinese deals, Belgium refusing Mounjaro coverage, and more